Assuntos
Anti-Infecciosos Locais/administração & dosagem , Cateteres de Demora/efeitos adversos , Violeta Genciana/administração & dosagem , Granuloma de Corpo Estranho/etiologia , Diálise Peritoneal Ambulatorial Contínua/efeitos adversos , Administração Tópica , Infecções Bacterianas/tratamento farmacológico , Infecções Bacterianas/etiologia , Infecções Bacterianas/microbiologia , Granuloma de Corpo Estranho/tratamento farmacológico , HumanosRESUMO
We report four cases of leprosy in renal transplant recipients, two of whom had the disease before transplantation and no signs of relapse even in the presence of immunosuppressive drugs. The other two cases presented with lepromatous and borderline (dimorphous) leprosy 5 months and 5 years after transplantation, respectively. The disease of the last patient was controlled with sulfone even in the presence of immunosuppressive drugs, but the mechanism whereby the first patient rapidly developed lepromatous leprosy is unclear, even though he was a home contact of a patient with lepromatous leprosy (his wife). In view of the data presented here, we do not contraindicate renal transplantation in patients with leprosy who frequently suffer changes in renal function. We believe that renal function should be periodically evaluated in patients with borderline and lepromatous leprosy.
